Comment on the work The place of Exemestane in the treatment of metastatic breast cancer in postmenopausal patients

被引：0
|
作者：
Krzakowski, Maciej [1 ]
机构：
[1] Ctr Onkol Inst Im Marii Sklodowskiej Curie, Klin Nowotworow Pluca & Klatki Piersiowej, Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2012年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：252 / 254
页数：3
相关论文
共 50 条
  • [1] The place of exemestane in the treatment of advanced breast cancer in postmenopausal patients
    Lacko, Aleksandra
    Duchnowska, Renata
    ONCOLOGY IN CLINICAL PRACTICE, 2012, 8 (06): : 246 - 251
  • [2] Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
    Kittaneh, Muaiad
    Gluck, Stefan
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 209 - 226
  • [3] The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'
    Atalay, G
    Dirix, L
    Biganzoli, L
    Beex, L
    Nooij, M
    Cameron, D
    Lohrisch, C
    Cufer, T
    Lobelle, JP
    Mattiaci, MR
    Piccart, M
    Paridaens, R
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 211 - 217
  • [4] Adjuvant treatment of breast cancer in postmenopausal women: role of exemestane
    Macpherson, Iain R. J.
    Lindsay, Colin
    Canney, Peter
    BREAST CANCER-TARGETS AND THERAPY, 2010, 2 : 59 - 70
  • [5] Examination of the use of Exemestane in patients with metastatic breast cancer
    Takashima, Seiki
    Kiyoto, Sachiko
    Takahashi, Mina
    Hara, Fumikata
    Takabatake, Daisuke
    Aogi, Kenjiro
    Ohsumi, Shozo
    BREAST CANCER, 2011, 18 (03) : 189 - 194
  • [6] Examination of the use of Exemestane in patients with metastatic breast cancer
    Seiki Takashima
    Sachiko Kiyoto
    Mina Takahashi
    Fumikata Hara
    Daisuke Takabatake
    Kenjiro Aogi
    Shozo Ohsumi
    Breast Cancer, 2011, 18 : 189 - 194
  • [7] Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer
    O'Shaughnessy, J.
    Campone, M.
    Brain, E.
    Neven, P.
    Hayes, D.
    Bondarenko, I.
    Griffin, T. W.
    Martin, J.
    De Porre, P.
    Kheoh, T.
    Yu, M. K.
    Peng, W.
    Johnston, S.
    ANNALS OF ONCOLOGY, 2016, 27 (01) : 106 - 113
  • [8] Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients
    Poggio, Francesca
    Lambertini, Matteo
    Blondeaux, Eva
    Vaglica, Marina
    Levaggi, Alessia
    Pronzato, Paolo
    Del Mastro, Lucia
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (09) : 1153 - 1161
  • [9] Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study
    C. Falandry
    M. Debled
    T. Bachelot
    T. Delozier
    J. Crétin
    P. Romestaing
    D. Mille
    B. You
    L. Mauriac
    E. Pujade-Lauraine
    G. Freyer
    Breast Cancer Research and Treatment, 2009, 116
  • [10] Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study
    Falandry, C.
    Debled, M.
    Bachelot, T.
    Delozier, T.
    Cretin, J.
    Romestaing, P.
    Mille, D.
    You, B.
    Mauriac, L.
    Pujade-Lauraine, E.
    Freyer, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (03) : 501 - 508
12345